Where is Pharmamab located?

Pharmamab is headquartered in Chieti, Italy.

Is Pharmamab a funded company?

Pharmamab is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Pharmamab rank among its competitors?

Pharmamab ranks 11th amongst 14 active competitors, of which 4 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Phagos, which secured $29.2M in Oct, 2025.

Who are the top competitors of Pharmamab?

Pharmamab's top competitors include Araris Biotech, CDI Labs and OmniAb. Among them, Phagos secured the most recent funding round in October, 2025.

Pharmamab - 2026 Company Profile, Team, Funding & Competitors

Pharmamab is a funded company based in Chieti (Italy), founded in 2010 by Stefano Iacobelli. It operates as a Develops therapeutic antibodies. The company has 14 active competitors, including 4 funded and 3 that have exited. Its top competitors include companies like Araris Biotech, CDI Labs and OmniAb.

Company Details

Pharmamab is engaged in the development of antibodies for therapeutic applications. The company develops a new generation of monoclonal antibodies involving conjugation with toxic modules, both drugs, and toxins. The company claims that its antibody has demonstrated in-vivo anti-tumor activity (humanized MP-AA-1), and it has started cGMP manufacturing of lead therapeutic mAb followed by initial screening in the patients.

Website: pharmamab.it
Email ID: *****@pharmamab.it
Phone Number: +39 **********

Key Metrics

Founded Year

2010

Location

Chieti, Italy

Stage

Funding Raised

Investors

Invent Innovation Ventures

Ranked

11^th among 14 active competitors

Similar Companies

Araris Biotech & 13 more

View Pharmamab's full profile

Pharmamab is a funded company. Pharmamab has 1 institutional investor.

View details of Pharmamab's funding rounds and investors

The founders of Pharmamab is Stefano Iacobelli.

Here are the details of Pharmamab's key team members:

Stefano Iacobelli: Founder & President of Pharmamab.
Contact Info: 1 phone number

View details of Pharmamab's Founder profiles and Board Members

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Pharmamab include Araris Biotech, CDI Labs and OmniAb. Here is the list of Top 10 competitors of Pharmamab, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Araris Biotech 2019, Zurich (Switzerland), Acquired	Developer of novel antibody-drug conjugate linker technology	$40.8M	Pureos Bioventures, 4Bio Capital & 8 others	58/100
2nd	CDI Labs 2001, Mayaguez (Puerto Rico), Seed	Provider of products and services for autoantibody detection and profiling	$2.1M	Broadoak Capital Partners, HHS	54/100
3rd	OmniAb 2012, Palo Alto (United States), Public	Therapeutic antibody discovery company providing diverse antibody repertoires and cutting-edge screening technologies	-	-	41/100
4th	Phagos 2021, Suresnes (France), Series A	Developer of AI-powered bioplatform for targeted bacterial treatments using phages	$31.6M	Demeter, Hoxton Ventures & 11 others	36/100
5th	RevMAb Biosciences 2012, San Francisco (United States), Series A	Providing antibodies and custom services based on its proprietary antibody generation method.	$6.64M	-	33/100
6th	BiCell Scientific 2017, Scottsdale (United States), Unfunded	Validated antibodies and custom antibody services for biomedical research	-	-	30/100
7th	AbCheck 2009, Pilsen (Czech Republic), Acquired	Developer of human therapeutic antibodies	-	-	26/100
8th	Single Cell Technology 2008, San Jose (United States), Seed	Pioneering antibody discovery platform delivering actionable leads through comprehensive data capture	$2.46M	-	26/100
9th	AMC Science 2024, Seoul (South Korea), Unfunded	Developer of therapeutic technologies focused on oncology, immunology, and ophthalmology	-	-	24/100
10th	Bailing Biotechnology 2015, Hangzhou (China), Unfunded	Developer of antibodies for research and development	-	-	24/100
11th	Pharmamab 2010, Chieti (Italy), Funding Raised	Develops therapeutic antibodies	-	Invent Innovation Ventures	22/100